Market open
DarioHealth/$DRIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About DarioHealth
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Ticker
$DRIO
Sector
Trading on
Industry
Health Care Technology
Headquarters
Employees
199
Website
DarioHealth Metrics
BasicAdvanced
$29M
-
-$0.61
1.56
-
Price and volume
Market cap
$29M
Beta
1.56
52-week high
$1.93
52-week low
$0.50
Average daily volume
319K
Financial strength
Current ratio
2.436
Quick ratio
2.017
Long term debt to equity
33.654
Total debt to equity
41.922
Management effectiveness
Return on assets (TTM)
-33.11%
Return on equity (TTM)
-65.68%
Valuation
Price to revenue (TTM)
1.276
Price to book
0.38
Price to tangible book (TTM)
-6.48
Price to free cash flow (TTM)
-0.892
Growth
Revenue change (TTM)
32.86%
Earnings per share change (TTM)
-68.27%
3-year revenue growth (CAGR)
9.65%
3-year earnings per share growth (CAGR)
-46.78%
What the Analysts think about DarioHealth
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for DarioHealth stock.
DarioHealth Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
DarioHealth Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
DarioHealth News
AllArticlesVideos
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth
Business Wire·3 weeks ago
DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for DarioHealth stock?
DarioHealth (DRIO) has a market cap of $29M as of April 16, 2025.
What is the P/E ratio for DarioHealth stock?
The price to earnings (P/E) ratio for DarioHealth (DRIO) stock is 0 as of April 16, 2025.
Does DarioHealth stock pay dividends?
No, DarioHealth (DRIO) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next DarioHealth dividend payment date?
DarioHealth (DRIO) stock does not pay dividends to its shareholders.
What is the beta indicator for DarioHealth?
DarioHealth (DRIO) has a beta rating of 1.56. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.